PSNL (PSNL) Stock Price & Analysis
PSNL (PSNL) fell 3.55% to USD 16.59 as of September 8, 2026 at 19:17 UTC, according to Nexqual real-time market data.
PSNL last closed at USD 16.59; the session ranged USD 16.55–17.35 on volume of 1,770,384 shares. Market capitalization is —, with a 52-week range of USD 4.96–18.89 (NGM). Source: Nexqual, September 8, 2026 at 19:17 UTC.
Key Statistics (as of September 8, 2026 at 19:17 UTC)
| Price | USD 16.59 |
|---|---|
| Change | ▼ 3.55% (down) |
| Previous Close | USD 16.59 |
| Open | USD 16.59 |
| Day Range | USD 16.55 – 17.35 |
| 52-Week Range | USD 4.96 – 18.89 |
| Volume | 1,770,384 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (PSNL)
Nexqual's technical model rates PSNL "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 8, 2026 at 19:17 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.76 (neutral) |
| vs SMA50 | Above (USD 14.61) |
| MACD | 0.87 (positive) |
From PSNL's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDNA | CareDx, Inc. | USD 49.8 | ▼ 0.12% |
| TWST | Twist Bioscience Corporation | USD 127.72 | ▼ 0.77% |
| VCYT | Veracyte, Inc. | USD 42.56 | ▼ 4.72% |
| CSTL | Castle Biosciences, Inc. | USD 32.73 | ▲ 0.25% |
| ARCT | Arcturus Therapeutics Holdings | USD 15.79 | ▲ 1.48% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 19:17 UTC. This page is informational and not investment advice.